Medical devices, healthcare technology and the business of care
PMA SUPPLEMENT · P060001/S052

Protégé GPS self-expanding Peripheral Stent System

Medtronic Vascular, Inc. · Decision date Nov 7, 2025

FDA DECISIONP060001/S052

What did the FDA approve?

FDA records P060001/S052 as a supplement to PMA P060001, with the supplement type “Real-Time Process”. The recorded decision is approval, dated Nov 7, 2025.

FDA approval order statement

Approval for an alternate modified stopcock from the supplier for the EverFlex self-expanding Peripheral Stent System and Protégé GPS Self-Expanding Peripheral Stent System.
Regulatory pathway
PMA supplement
Supplement type
Real-Time Process
Clinical specialty
Cardiovascular
Decision date
Nov 7, 2025
FDA change category
Change Design/Components/Specifications/Material

FDA source record

Regulatory record facts

Identifier
P060001/S052
Regulatory pathway
PMA supplement
Product code
NIM
Decision code
APPR
Decision date
Nov 7, 2025
Source update
Nov 9, 2026
Original record
Open FDA source record

About this medical device

FDA device category: Stent, carotid.

Product code
NIM
FDA device class
3

For the original device and its historical approval scope, see PMA P060001. Subsequent supplements may change the device or its indications.

FDA decision timeline

  1. P060001 · Original PMA

    PROTEGE GPS AND PROTEGE RX CAROTID STENT SYSTEMS

  2. P060001/S049 · Related supplement

    Protégé RX Carotid Stent System

  3. P060001/S050 · Related supplement

    Protege RX Carotid Stent System; Protege GPS Self-Expanding Peripheral Stent System

  4. P060001/S051 · Related supplement

    Protege RX Carotid Stent System

  5. P060001/S052 received

    Application receipt date recorded by FDA.

  6. P060001/S052 · FDA decision

    Real-Time Process

  7. P060001/S053 · Related supplement

    Protégé GPS Self-expanding Peripheral Stent System

  8. P060001/S054 · Related supplement

    Protégé RX Carotid Stent System

  9. P060001/S056 · Related supplement

    Protege RX Carotid Stent System; Protege GPS Self-Expanding Peripheral Stent System

  10. P060001/S055 · Related supplement

    Protege RX Carotid Stent System; Protege GPS Self-Expanding Peripheral Stent System

  11. P060001/S057 · Related supplement

    Protégé GPS Self-Expanding Peripheral Stent System; Protégé RX Carotid Stent System

  12. P060001/S058 · Related supplement

    Protege GPS Self-expanding Peripheral Stent System

  13. P060001/S059 · Related supplement

    Protégé GPS Self-Expanding Peripheral Stent System; Protégé RX Self-Expanding Carotid Stent System

  14. P060001/S060 · Related supplement

    PROTEGE GPS AND PROTEGE RX CAROTID STENT SYSTEMS

Timeline entries are records held by MedtechLedger for P060001. View FDA’s full supplement list.

Related devices and submissions

Same PMA: P060001

Product / regulatory recordCompanyPathwayDecision dateSource
Medtronic Vascular, Inc.PMA approvalJan 24, 2007FDA
Medtronic Vascular, Inc.PMA supplementJul 17, 2025FDA
Medtronic Vascular, Inc.PMA supplementJul 25, 2025FDA
Medtronic Vascular, Inc.PMA supplementAug 13, 2025FDA
Medtronic Vascular, Inc.PMA supplementDec 16, 2025FDA
Medtronic Vascular, Inc.PMA supplementJan 23, 2026FDA
Medtronic Vascular, Inc.PMA supplementFeb 11, 2026FDA
Medtronic Vascular, Inc.PMA supplementFeb 20, 2026FDA
Medtronic Vascular, Inc.PMA supplementMar 23, 2026FDA
Medtronic Vascular, Inc.PMA supplementJul 10, 2026FDA
Medtronic Vascular, Inc.PMA supplementOct 16, 2026FDA
Medtronic Vascular, Inc.PMA supplementNov 5, 2026FDA

Explore the linked device profile

Other records with product code NIM

A shared product code identifies a classification relationship; it does not establish clinical equivalence.

Regulatory context

A PMA supplement records a change to a device with an existing premarket approval. The supplement’s approval applies to the change described in that submission.

FDA describes the real-time supplement process as a review route for minor changes to a device, including certain design, software, sterilization or labeling changes.

Read our guide to FDA clearance and approval · FDA’s explanation of this pathway

Manufacturer intelligence

Medtronic Vascular, Inc.

Headquarters
Not reported
Brand website
medtronic.com
FDA applicant address
3033 Campus Dr., Plymouth, MN, 55441

Sources and methodology

FDA fields and approval-order wording are presented as source information. MedtechLedger explanations are identified separately and describe the scope of the recorded decision. Indications from an original PMA are historical unless confirmed against subsequent labeling and supplements.

How we use FDA records